Rwanda government signs an agreement with German company BioNTech for its first end-to-end manufacturing of mRNA-based vaccines in Africa. BioNTech said the facility is expected to produce about 50 million doses per year, with the capacity likely to increase.
Read the original article here: https://apnews.com/article/coronavirus-pandemic-business-health-rwanda-coronavirus-vaccine-f800599b45c433f09a03bdd625c46ddb